Pfizer drug from Medivation deal shows promise in breast cancer: study

A breast cancer drug that Pfizer Inc acquired with its $14 billion purchase of Medivation showed promising anti-tumor activity following prior treatments and a modest ability to hold the disease in check, according to data from a mid-stage study released on Wednesday.The drug, talazoparib, belongs t
Read More

Bayer gets FDA priority review for blood cancer drug

FRANKFURT, Germany German drugmaker Bayer won the U.S. Food and Drug Administration's priority review status for an experimental drug for a difficult to treat type of blood cancer, bolstering its development pipeline. Based on results of a Phase II study, the FDA plans to review Bayer's copanlisib w
Read More
Page 13 of 13« First...910111213